Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Interferon-Induced Transmembrane Protein 1 (IFITM1) Peptide

IFITM1 Reactivity: Human, Rat Host: Synthetic BP
Catalog No. ABIN2800827
  • Target See all IFITM1 products
    IFITM1 (Interferon-Induced Transmembrane Protein 1 (IFITM1))
    Peptide Type
    Synthetic
    Origin
    Human, Rat
    Source
    • 2
    Synthetic
    Application
    Blocking Peptide (BP)
    Characteristics
    The peptide is used to block Anti-CD225 Antibody reactivity.
  • Application Notes
    Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    Lyophilized powder
    Storage
    -20 °C
    Storage Comment
    Shipped at 4°C. Store at -20°C for one year.
    Expiry Date
    12 months
  • Target
    IFITM1 (Interferon-Induced Transmembrane Protein 1 (IFITM1))
    Synonyms
    9-27 Peptide, CD225 Peptide, DSPA2a Peptide, IFI17 Peptide, LEU13 Peptide, 1110036C17Rik Peptide, Mil-2 Peptide, Mil2 Peptide, interferon induced transmembrane protein 1 Peptide, interferon induced transmembrane protein 1 (9-27) Peptide, Ifitm1 Peptide, IFITM1 Peptide
    Background
    CD225, IFI17, Interferon-induced transmembrane protein 1, Dispanin subfamily A member 2a, DSPA2a, Interferon-induced protein 17, Interferon-inducible protein 9-27, Leu-13 antigen, CD225
    Gene ID
    8519
    UniProt
    P13164
You are here:
Support